GOODRX HOLDINGS INC-CLASS A (GDRX) Stock Fundamental Analysis
NASDAQ:GDRX - Nasdaq - US38246G1085 - Common Stock - Currency: USD
Overall GDRX gets a fundamental rating of 5 out of 10. We evaluated GDRX against 39 industry peers in the Health Care Technology industry. Both the profitability and the financial health of GDRX get a neutral evaluation. Nothing too spectacular is happening here. GDRX is valued quite cheap, while showing a decent growth score. This is a good combination! This makes GDRX very considerable for value investing!
1. Profitability
1.1 Basic Checks
GDRX had positive earnings in the past year.
GDRX had a positive operating cash flow in the past year.
In the past 5 years GDRX reported 4 times negative net income.
In the past 5 years GDRX always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of -1.20%, GDRX belongs to the top of the industry, outperforming 83.78% of the companies in the same industry.
GDRX's Return On Equity of -2.33% is amongst the best of the industry. GDRX outperforms 83.78% of its industry peers.
GDRX's Return On Invested Capital of 1.88% is fine compared to the rest of the industry. GDRX outperforms 75.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.2% | ||
| ROE | -2.33% | ||
| ROIC | 1.88% |
ROA(3y)-1.39%
ROA(5y)-1.42%
ROE(3y)-2.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GDRX's Operating Margin of 3.74% is fine compared to the rest of the industry. GDRX outperforms 75.68% of its industry peers.
GDRX has a better Gross Margin (93.52%) than 100.00% of its industry peers.
GDRX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.74% | ||
| PM (TTM) | N/A | ||
| GM | 93.52% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.26%
GM growth 5Y-1.37%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GDRX is destroying value.
GDRX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for GDRX has been increased compared to 5 years ago.
The debt/assets ratio for GDRX is higher compared to a year ago.
2.2 Solvency
GDRX has an Altman-Z score of 1.30. This is a bad value and indicates that GDRX is not financially healthy and even has some risk of bankruptcy.
GDRX has a Altman-Z score of 1.30. This is comparable to the rest of the industry: GDRX outperforms 59.46% of its industry peers.
The Debt to FCF ratio of GDRX is 5.55, which is a neutral value as it means it would take GDRX, 5.55 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of GDRX (5.55) is better than 64.86% of its industry peers.
GDRX has a Debt/Equity ratio of 0.70. This is a neutral value indicating GDRX is somewhat dependend on debt financing.
GDRX's Debt to Equity ratio of 0.70 is on the low side compared to the rest of the industry. GDRX is outperformed by 72.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | 5.55 | ||
| Altman-Z | 1.3 |
ROIC/WACC0.18
WACC10.3%
2.3 Liquidity
A Current Ratio of 5.48 indicates that GDRX has no problem at all paying its short term obligations.
GDRX has a better Current ratio (5.48) than 91.89% of its industry peers.
GDRX has a Quick Ratio of 5.48. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.48, GDRX belongs to the best of the industry, outperforming 91.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.48 | ||
| Quick Ratio | 5.48 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 18.52% over the past year.
GDRX shows a small growth in Revenue. In the last year, the Revenue has grown by 7.13%.
The Revenue has been growing by 24.63% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)18.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)7.13%
Revenue growth 3Y10.86%
Revenue growth 5Y24.63%
Sales Q2Q%8.5%
3.2 Future
The Earnings Per Share is expected to grow by 21.27% on average over the next years. This is a very strong growth
GDRX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.60% yearly.
EPS Next Y24.95%
EPS Next 2Y20.62%
EPS Next 3Y20.59%
EPS Next 5Y21.27%
Revenue Next Year5.44%
Revenue Next 2Y4.73%
Revenue Next 3Y5.51%
Revenue Next 5Y6.6%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 15.03 indicates a correct valuation of GDRX.
GDRX's Price/Earnings ratio is rather cheap when compared to the industry. GDRX is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.63. GDRX is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 11.81, the valuation of GDRX can be described as reasonable.
Based on the Price/Forward Earnings ratio, GDRX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
GDRX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.03 | ||
| Fwd PE | 11.81 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GDRX is valued cheaper than 86.49% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 81.08% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.72 | ||
| EV/EBITDA | 15.54 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GDRX's earnings are expected to grow with 20.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2Y20.62%
EPS Next 3Y20.59%
5. Dividend
5.1 Amount
GDRX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
4.81
-0.05 (-1.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners60.62%
Inst Owner Change-3.86%
Ins Owners12.28%
Ins Owner Change13.7%
Market Cap1.83B
Analysts75.83
Price Target7.07 (46.99%)
Short Float %7.59%
Short Ratio6.2
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.6%
Min EPS beat(2)-10.15%
Max EPS beat(2)-9.04%
EPS beat(4)2
Avg EPS beat(4)0.37%
Min EPS beat(4)-10.15%
Max EPS beat(4)16.19%
EPS beat(8)6
Avg EPS beat(8)11.07%
EPS beat(12)9
Avg EPS beat(12)18.26%
EPS beat(16)11
Avg EPS beat(16)14.54%
Revenue beat(2)0
Avg Revenue beat(2)-2.02%
Min Revenue beat(2)-2.16%
Max Revenue beat(2)-1.88%
Revenue beat(4)0
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)-1.06%
Revenue beat(8)1
Avg Revenue beat(8)-1.65%
Revenue beat(12)2
Avg Revenue beat(12)-1.4%
Revenue beat(16)3
Avg Revenue beat(16)-1.24%
PT rev (1m)-3.05%
PT rev (3m)-26.58%
EPS NQ rev (1m)-0.11%
EPS NQ rev (3m)-0.52%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.26%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.03 | ||
| Fwd PE | 11.81 | ||
| P/S | 2.32 | ||
| P/FCF | 20.72 | ||
| P/OCF | 11.82 | ||
| P/B | 2.63 | ||
| P/tB | 16.41 | ||
| EV/EBITDA | 15.54 |
EPS(TTM)0.32
EY6.65%
EPS(NY)0.41
Fwd EY8.47%
FCF(TTM)0.23
FCFY4.83%
OCF(TTM)0.41
OCFY8.46%
SpS2.07
BVpS1.83
TBVpS0.29
PEG (NY)0.6
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.2% | ||
| ROE | -2.33% | ||
| ROCE | 2.38% | ||
| ROIC | 1.88% | ||
| ROICexc | 2.86% | ||
| ROICexgc | 10.06% | ||
| OM | 3.74% | ||
| PM (TTM) | N/A | ||
| GM | 93.52% | ||
| FCFM | 11.19% |
ROA(3y)-1.39%
ROA(5y)-1.42%
ROE(3y)-2.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.26%
GM growth 5Y-1.37%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | 5.55 | ||
| Debt/EBITDA | 3.95 | ||
| Cap/Depr | 70.81% | ||
| Cap/Sales | 8.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 125.48% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.48 | ||
| Quick Ratio | 5.48 | ||
| Altman-Z | 1.3 |
F-Score6
WACC10.3%
ROIC/WACC0.18
Cap/Depr(3y)84.55%
Cap/Depr(5y)98.02%
Cap/Sales(3y)6.42%
Cap/Sales(5y)5.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y24.95%
EPS Next 2Y20.62%
EPS Next 3Y20.59%
EPS Next 5Y21.27%
Revenue 1Y (TTM)7.13%
Revenue growth 3Y10.86%
Revenue growth 5Y24.63%
Sales Q2Q%8.5%
Revenue Next Year5.44%
Revenue Next 2Y4.73%
Revenue Next 3Y5.51%
Revenue Next 5Y6.6%
EBIT growth 1Y293.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year51.99%
EBIT Next 3Y21.41%
EBIT Next 5Y17.2%
FCF growth 1Y-23.4%
FCF growth 3Y-4.75%
FCF growth 5Y14.57%
OCF growth 1Y-5.86%
OCF growth 3Y1.74%
OCF growth 5Y25.01%